Summary
Many diabetes patients experience hypoglycaemia, when their blood sugar levels become too low. Symptoms include behavioural changes, memory loss and confusion, which can result in accidents and falls and, in the worst cases, in hospitalisation or death. Worries about hypoglycaemia represent a serious psychological burden for people with diabetes.
Despite its seriousness, little is known about hypoglycaemia. The Hypo-RESOLVE project aims to change that by adding to our understanding of the underlying causes of the condition, as well as its predictors and consequences. They will also analyse the financial costs of hypoglycaemia. Ultimately, the hope is that the project results will pave the way for new, better treatments for people with diabetes that will help them to maintain healthy blood sugar levels.
Achievements & News
January 2023
Many people with diabetes experience hypoglycaemia, when blood sugar levels become too low. IMI project Hypo-RESOLVE is shedding new light...
The Hypo-RESOLVE project wants to single out the risk factors for severe hypoglycaemic episodes, where diabetes patients’ blood sugar levels fall to dangerously low levels. ###Although there are certain widely recognised risk factors for hypoglycaemia like exercise, skipped meals or insulin dosing errors, hypoglycaemic episodes very often also occur quite unexpectedly. If a ‘hypo’ occurs, you have to act quickly to bring your glucose levels back to normal and make sure you’re not a threat to yourself.
Needless to say, this often interferes directly with daily activities. Episodes can even occur without causing any symptoms, and sometimes recovery is spontaneous. Not uncommonly, a partner or family member recognises it before the patient does. ‘In the long term,’ says Hypo-RESOLVE coordinator Bastiaan de Galan of the Radboud University Medical Centre in Nijmegen, ‘hypo events can cause fear and avoidant behaviour, which makes overall glucose control even more difficult. Severe episodes can increase the risk of cardiovascular disease, although we don’t know yet whether this relation is causal.’
The Hypo-RESOLVE project wants to find out more about the mechanisms of hypoglycaemic episodes beyond what is already known, including their effect on the psychosocial well-being of people who experience them. In an interview with the IMI Programme office, Bastiaan de Galan and Jill Carlton of the University of Sheffield describe how the project is working to tackle the challenge of hypoglycaemic episodes.
Find out more
- Read the interview in full
Participants
Show participants on mapEFPIA companies
- Abbott Diabetes Care, Alameda, United States
- Eli Lilly And Company LTD, Basingstoke, United Kingdom
- Medtronic International Trading SARL, Tolochenaz, Switzerland
- Novo Nordisk A/S, Bagsvaerd, Denmark
Universities, research organisations, public bodies, non-profit groups
- Centre Hospitalier Universitaire Montpellier, Montpellier, France
- King'S College London, London, United Kingdom
- Medizinische Universitat Graz, Graz, Austria
- Region Hovedstaden, Hilleroed, Denmark
- SIB Institut Suisse De Bioinformatique, CH-660-0733998-3, Genève, Switzerland
- Stichting Radboud Universitair Medisch Centrum, Nijmegen, Netherlands
- Syddansk Universitet, Odense, Denmark
- The University Of Edinburgh, Edinburgh, United Kingdom
- The University Of Sheffield, Sheffield, United Kingdom
- Universita Degli Studi Di Padova, Padova, Italy
- University Of Dundee, Dundee, United Kingdom
- University Of Leicester, Leicester, United Kingdom
- University of Cambridge, Cambridge, United Kingdom
Small and medium-sized enterprises (SMEs) and mid-sized companies (<€500 m turnover)
- Eurice European Research And Project Office GMBH, Saarbrücken, Germany
Associated partners
- Breakthrough T1d, New York, United States
- Federation Internationale Du Diabete, Brussels, Belgium
- The Leona M. And Harry B. Helmsley Charitable Trust, New York, United States
- Unitio Inc, Boston, United States
Third parties
- Sheffield Teaching Hospitals Nhs Foundation Trust, Sheffield, United Kingdom
- University Hospitals Of Leicester Nhs Trust, Leicester, United Kingdom
Participants | |
---|---|
Name | EU funding in € |
Centre Hospitalier Universitaire Montpellier | 445 982 |
Eurice European Research And Project Office GMBH | 676 149 |
King'S College London | 385 703 |
Medizinische Universitat Graz | 828 737 |
Region Hovedstaden | 1 011 732 |
SIB Institut Suisse De Bioinformatique, CH-660-0733998-3 | 934 250 |
Stichting Radboud Universitair Medisch Centrum | 2 008 957 |
Syddansk Universitet | 1 354 981 |
The University Of Edinburgh | 1 303 699 |
The University Of Sheffield | 2 000 222 |
Universita Degli Studi Di Padova | 392 688 |
Universite De Lausanne (left the project) | 955 601 |
University of Cambridge | 662 703 |
University Of Dundee | 383 623 |
University Of Leicester | 35 276 |
Third parties | |
Name | Funding in € |
Sheffield Teaching Hospitals Nhs Foundation Trust | 67 913 |
University Hospitals Of Leicester Nhs Trust | 1 841 |
Total Cost | 13 450 057 |